Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Tel Aviv University | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators hypothesis is that eating whey protein in breakfast will reduce overall postprandial glycemia in individuals with type 2 diabetes (T2D).
It was shown that increasing protein at breakfast results in reduced overall postprandial glycemia in obese individuals This study was undertaken to evaluate whether compared to proteins like tuna, eggs and soy, the intake of whey protein in the breakfast is more effective to reduce overall postprandial glycemia (PPHG) in T2D individuals.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Arm 1-Whey protein | Experimental | In the Arm 1-Whey protein Breakfast the participant will consume 42 g protein at breakfast mainly from whey |
|
| Arm 2 Breakfast- other proteins | Active Comparator | In the Arm 2 Breakfast- other proteins sources (No Whey) the participants will consume 42 g protein from other sources (no Whey) at breakfast |
|
| Arm 3 Breakfast- low protein | Placebo Comparator | In the Arm 3: breakfast with low proteins content, the participant will consume 22 g protein at breakfast |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Arm1: Whey protein | Other | Arm1: Whey protein:The participants will consume 42 g protein, namely from Whey protein in the breakfast |
|
| Measure | Description | Time Frame |
|---|---|---|
| Plasma glucose | Overall postprandial glycemia after breakfast, lunch and dinner | 3 month |
| Measure | Description | Time Frame |
|---|---|---|
| Satiety | Postprandial satiety after breakfast lunch and dinner, assessed with visual analog scale. | 3 month |
| Change in body weight | Body weight will be assessed every every two weeks during 3 month |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Daniela Jakubowicz, MD | Wolfson Medical Center | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Arm 2 Breakfast- other proteins | Other | Arm 2 Breakfast- other proteins: The participants will be assigned to 42 g protein of other protein sources at breakfast |
|
|
| Arm 3 Breakfast- low protein | Other | Arm 3: Low protein' :The participants will consume 22 g protein at breakfast |
|
|
| 3 month |
| D004700 | Endocrine System Diseases |